Has Bailey Griffin, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $44,052 in general payments to Bailey Griffin, DPM across 191 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bailey Griffin, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bailey Griffin, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bailey Griffin, DPM

Foot & Ankle Surgery · Humble, TXNPI 1003164146

Payments from drug & device makers

$44,052in general payments, 2019–2025

Across 191 payments — averaging $230.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Triad Life Sciences Inc.$38K
Stryker$1K
Smith+Nephew$554
Sanara Medtech Inc.$471
Zimmer Biomet$209
Heartflow, Inc.$205
plus $3K from 48 others

What the payments were for

Food & beverage$5,65213%
Other$38,40087%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Triad Life Sciences Inc.	5	$38,416
Stryker	33	$1,310
Smith+Nephew	35	$554
Sanara Medtech Inc.	5	$471
Zimmer Biomet	5	$209
Heartflow, Inc.	3	$205
Cvrx, Inc.	2	$198
Abbott	5	$184
Organogenesis Inc.	1	$182
Treace Medical Concepts, Inc.	7	$158
Impulse Dynamics (USA) Inc.	8	$156
Bone Support Inc.	1	$154
Tactile Systems Technology Inc	10	$139
Imbed Biosciences Inc.	2	$127
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$114
Esperion Therapeutics, Inc.	5	$106
Canon Medical Systems USA, Inc.	3	$99
Kestra Medical Technology Services, Inc.	1	$93
Mimedx Group, Inc.	3	$91
Johnson & Johnson	5	$90
Paratek Pharmaceuticals, Inc.	5	$89
Amgen	5	$85
Merck	4	$56
Avita Medical Americas, LLC	1	$48
Baudax Bio Inc.	2	$43
Solventum Corporation	2	$40
Convatec Inc.	2	$38
Medshape, Inc.	1	$34
Amarin Pharma, Inc.	2	$33
Endologix LLC	1	$31
Polynovo North America LLC	1	$30
Lifenet Health	1	$30
Biom'up France SAS	1	$29
Globus Medical	1	$28
Urgo Medical North America, LLC	1	$27
Regeneron	1	$27
Reprise Biomedical, Inc.	1	$26
Vertex	1	$25
Sanofi-aventis U.S. LLC	1	$24
Sandoz	1	$22
Nevro Corp.	1	$22
Melinta Therapeutics, LLC	1	$22
Kerecis Limited	1	$20
Bioventus LLC	1	$20
Sebela Pharmaceuticals Inc.	1	$19
KCI USA, Inc.	1	$19
Arthrosurface Incorporated	1	$19
Medtronic	1	$19
Innovation Technologies Inc	1	$18
Inari Medical, Inc.	1	$16
GRT US Holding, Inc.	1	$14
Arteriocyte Medical Systems, Inc.	1	$12
Wound Management Technologies, Inc	1	$10
Ossio Inc	1	$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,052 in reported general payments places this provider in the 90th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$963,934

Medicare patients

433

Services billed

4,211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gentamicin Sulfate	279	$10,451
Naftifine Hcl	12	$3,529
Gabapentin	333	$2,776
Pregabalin	25	$682
Doxycycline Monohydrate	51	$573
Econazole Nitrate	17	$563
Methylprednisolone	77	$517
Terbinafine Hcl	45	$494
Ketoconazole	27	$463
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	13	$434
Clindamycin Hcl	44	$431
Mupirocin	21	$269
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	33	$252
Ciprofloxacin Hcl	34	$216
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	62	$195

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Humble

Richard PollakSan Antonio$6.1M
Joseph CaporussoMcAllen$6M
Mark DaltonAustin$4.1M
William McGarveyKaty$3.5M
Eugene CurryDallas$3.1M
Chad HowzeSan Antonio$2.4M
Graham HamiltonEdinburg$2.1M
Kevin VarnerHouston$1.1M
Paul KimDallas$972K
Mark RobsonAustin$957K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →